MALAT1 and hepatocellular carcinoma: Previous studies have reported that the MALAT1 polymorphisms were associated with cancer development, carcinogenesis and prognosis in various cancers such as hepatocellular carcinoma [29], cervical cancer [30], oral squamous cell carcinoma [31], and prostate cancer [32].